Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Dec;19(12):555-60.
doi: 10.1023/a:1021259031267.

The maturity of human cumulus-free oocytes is positively related to blastocyst development and viability

Fu-Jen Huang  1 , Hsuan-Wei Huang, Kuo-Chung Lan, Fu-Tsai Kung, Yi-Chi Lin, Hsueh-Wen Chang, Shiuh-Young Chang
Affiliations

The maturity of human cumulus-free oocytes is positively related to blastocyst development and viability

Fu-Jen Huang et al. J Assist Reprod Genet. 2002 Dec.

Abstract

Purpose: We investigated whether the human oocyte maturity at the removal of cumulus/corona cells affects the embryo outcome in vitro.

Methods: A total of 620 oocytes, which subsequently underwent blastocyst culture, were included in this analysis. Oocytes that were in prophase or Metaphase I of meiosis at the removal of cumulus/corona cells were in Group II. Oocytes that were in Metaphase II at the removal of cumulus/corona cells were in Group I.

Results: Group I oocytes yielded the highest fertilization rates (96.3% vs. 77.1%, P < 0.001). The incidence of Group II oocytes developing to the blastocyst stage was significantly less than from Group I oocytes (38.1% vs. 86.1%, P < 0.001). The percentage of top-scoring blastocysts from Group I oocytes was higher than that of Group II oocytes (95.4% vs. 76.2%, P < 0.001).

Conclusions: Oocyte maturity at the removal of cumulus/corona cells needs to be considered in selecting good quality blastocysts for embryo transfer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Diamond MP, Hill GA, Webster BW, Herbert CM, Rogers BJ, Osteen KG, Maxson WS, Vaughn WK, Wentz AC. Comparison of human menopausal gonadotropin, clomiphen citrate, and combined human menopausal gonadotropin-clomiphene citrate stimulation protocols for in vitro fertilization. Fertil Steril. 1986;46:1108–1112. - PubMed
    1. Nevus S, Hedon B, Bringer J, Chinchole JM, Arnal F, Humeau C, Cristol P, Viala JL. Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil Steril. 1987;47:639–643. - PubMed
    1. Hwang FR, Chang MY, Soong YK. Gonadotropin stimulation after pituitary desensitization with leuprolide acetate comparison of FSH/hMG andhMGalone cycles—A study of 166 cases. Chang Gung Med J. 1993;16:223–230. - PubMed
    1. Strickler RC, Radwanska E, Williams DB. Controlled ovarian hyperstimulation regimens in assisted reproductive technologies. Am J Obstet Gynecol. 1995;172:766–773. - PubMed
    1. Hansen LM, Batzer FR, Gutmann JN, Corson SL, Kelly MP, Gocial B. Evaluating ovarian reserve: Follicle stimulating hormone and oestradiol variability during cycle days 2–5. Hum Reprod. 1996;11:486–489. - PubMed